MedPath

Tailoring evidence-based psychological therapy for people with common mental disorder including psychotic experiences work package 3d: a feasibility study

Not Applicable
Recruiting
Conditions
Mental health
Mental and Behavioural Disorders
Registration Number
ISRCTN16318194
Lead Sponsor
Cambridgeshire and Peterborough NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

1. IAPT therapist - Training inclusion criteria:
1.1 Qualified Step 3 IAPT therapist.
1.2 Willing and able to participate in TYPPEX training and supervision.
2. IAPT User - pseudonymised clinical data collection inclusion criteria:
2.1 Accepted onto the IAPT caseload for therapy and therefore meet service specific inclusion criteria to access IAPT treatment,
2.2 Meet current criteria for IAPT Step 3 treatment,
2.3 Presence of psychotic experiences, according to CAPE-P15 cut-off values of 1.47 on both the frequency and distress sub-scales.
3. IAPT User - Health economic questionnaires inclusion criteria
3.1 Meets IAPT User Eligibility Criteria for pseudonymised clinical data collection
3.2 In the judgement of the treating therapist has sufficient proficiency in English to complete research questionnaires.

Exclusion Criteria

1. IAPT Therapist - Training exclusion criteria:
1.1 Has not completed Step 3 High Intensity IAPT training.
1.2 Works across more than one locality IAPT team.
2. IAPT User - pseudonymised clinical data collection exclusion criteria
2.1 Presence of mental disorder based on standard IAPT assessment meriting routine referral to NICE step 4 treatment, i.e. to secondary mental health services.
3. IAPT User Health Economic Questionnaires exclusion criteria:
3.1 None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reliable Recovery proportion rate for people with psychotic experiences (the proportion of service users reaching scores below 10 in PHQ-9 and 8 in GAD-7) measured via scores on the routinely collected PHQ-9 and GAD-7 and additionally at 24 weeks post-therapy commencement.
Secondary Outcome Measures
NameTimeMethod
<br> 1. Feasibility of collecting health economics data via the EQ-5D and Adult Service Use Schedule to inform definitive RCT<br> 2. Recruitment rate of consented CAPE+ IAPT users for health economic data collection<br> 3. Assessment of the most feasible and effective methods of collecting health economic data<br> 4. Feasibility of using an adapted version of the Early Intervention in Psychosis Adult Service Use Schedule (EI-ADSUS) with the IAPT patient population<br>
© Copyright 2025. All Rights Reserved by MedPath